Call to arrange a consultation
+1 416 777 0888
Search the site
Aragon Pharmaceuticals, Inc. et al. v. Sandoz Canada Inc.
2025
T-9-25
Pending
6(1) PM(NOC) Regulations
Application under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations regarding apalutamide.
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team.
.jpg)
%20(1).jpg)
.jpg)
